BridgeMD
New treatment option for Unruptured Intracranial Aneurysm
Official title Patients with Unruptured IntraCranial ANeurysms: Evaluation of the Benefits of Allied Health FollOw-uP in a RandomizEd Controlled Trial
ClinicalTrials.gov ID: NCT06708078
What this study is testing
- What it's testing
- The CANHOPE study falls within the scope of research on patients' experiences and the improvement of their management through interventions meeting their needs. The study protocol assesses a support program for patients with untreated intracranial aneurysms (ICAs), for whom several sources of data converge in describing inadequacies in patients' care pathway and a deleterious impact on their health.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patient with newly diagnosed (\<9 months) untreated Intracranial Aneurysm
- Patient with untreated Intracranial Aneurysm monitored by imaging
- Patient over 18
- Patient agreeing to participate in the study and having signed the consent form
You likely can't join if
- Patient with a history of ruptured Intracranial Aneurysm
- Patient under guardianship or curatorship
- Patient diagnosed with a syndrome known to cause Intracranial Aneurysm :
- Marfan syndrome
- AOS (Aneurysm Osteoarthritis Syndrome) with SMAD 3 mutations
- Type II and IV Elhers Danlos syndrome
See the full eligibility criteria
- Patient with newly diagnosed (\<9 months) untreated Intracranial Aneurysm
- Patient with untreated Intracranial Aneurysm monitored by imaging
- Patient over 18
- Patient agreeing to participate in the study and having signed the consent form
- Patient with a history of ruptured Intracranial Aneurysm
- Patient under guardianship or curatorship
- Patient diagnosed with a syndrome known to cause Intracranial Aneurysm :
- Marfan syndrome
- AOS (Aneurysm Osteoarthritis Syndrome) with SMAD 3 mutations
- Type II and IV Elhers Danlos syndrome
- Autosomal dominant polycystic fibrosis
- Moya-Moya syndrome
- Patient with:
- Dissecting or fusiform Intracranial Aneurysm
- Intracranial Aneurysm associated with an arteriovenous malformation
- Blister-like Intracranial Aneurysm
- Mycotic Intracranial Aneurysm
The study team makes the final eligibility decision.
Where it's taking place
- Nantes, Loire-Atlantique, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Nantes, Loire-Atlantique, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.